StonvexLoading…
StonvexStonvexStonvexCore line items from EVRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.40B | $1.35B | $5.71B | $4.41B | $2.65B |
Operating Income | Not available | $318.40M | $1.53B | $1.29B | $635.40M |
Net Income | Not available | $151.50M | $855.60M | $771.30M | $296.30M |
EPS (Diluted) | $0.94 | $0.64 | $3.66 | $3.31 | $1.28 |
Total Assets | Not available | $34.48B | $33.95B | $33.44B | $32.91B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $18.40M | $19.80M | $27.50M | $27.80M |
Free Cash Flow OCF − CapEx | Not available | $-489.40M | $-751.70M | $-221.20M | $-446.60M |
Shares Outstanding | Not available | 235.60M | 233.60M | 233.00M | 232.40M |